Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injection Site Cooling for CNTX-4975 Pain
NCT03472677Phase 1Completed
- Sponsor
- Centrexion Therapeutics
- Start
- Mar 2018
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of capsaicin in osteoarthritis (OA) (4 cohorts), sponsored by Centrexion Therapeutics. Primary endpoint: Numerical Pain Rating Scale (NPRS): Injection-site Pain at Day 7. Started Mar 2018; status: completed.
02
Drugs
capsaicin
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03472677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03472677.